NCT04444102

Brief Summary

The goal of this study is to explore the impact of two types of yoga-based body stretching (mild and intense) on dynamic changes of Systemic Inflammatory Cytokines (SICs) and Specialized Pro-resolving Mediators (SPMs) in yoga-naïve subjects.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 30, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 23, 2020

Completed
3 months until next milestone

First Posted

Study publicly available on registry

June 23, 2020

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
Last Updated

January 16, 2024

Status Verified

January 1, 2024

Enrollment Period

4.3 years

First QC Date

March 23, 2020

Last Update Submit

January 12, 2024

Conditions

Keywords

stretchingyogamind-body therapiesinflammation

Outcome Measures

Primary Outcomes (1)

  • Feasibility of a pilot study including one session of acute stretching and serial blood samples over a period of 24 hours.

    * Study recruitment will be completed within 9 months * \>70% of participants will complete two study visits * Participants will adhere to study protocol, including completion of outcome assessments (\> 90%) and complying with stretching instructions specific to the mild and intense stretching protocol (confirmed with video analysis) * There will be no serious adverse events reported.

    Two consecutive study visits per participants over a period of 24 hours

Secondary Outcomes (2)

  • Systemic inflammatory cytokines

    Baseline, 0-, 30-, 60-, 120-, 180-minutes and 24 hours post intervention.

  • Specialized pro-resolving mediators (SPMs)

    Baseline, 0-, 30-, 60-, 120-, 180-minutes and 24 hours post intervention.

Study Arms (3)

Control group (CG)

NO INTERVENTION

Those subjects randomized to the CG will be offered reading options that do not evoke high emotional distress. They will spend an hour reading.

Stretching protocol 1, Mild Stretching Group (MSG)

EXPERIMENTAL

The protocol starts with 5 minutes of instruction about finding a range of stretching representing approximately 50% of the range of motion and pain-free. The instructor will also wear wrist and ankle reflective bands as body-marks to show a posture with 100% stretch and then corrected to 50%. Once the participant grasps the concept the routine will begin with 5 minutes of warm-up, followed by stretching exercises targeting 10 anatomical groups. Each posture will last 1 minute divided in 30 seconds of settling into each posture and 30 seconds of holding. Each session will be video recorded to analyze the stretching range, only if the participant agrees at the informed consent visit. Participants will be encouraged to find their own 50% with some feedback from the instructor.

Procedure: Yoga-based stretching

Stretching protocol 2, Intense Stretching Group (ISG):

EXPERIMENTAL

The protocol starts with 5 minutes of instruction about finding a range of stretching representing approximately 100% of the range of motion and pain-free. The instructor will also wear wrist and ankle reflective bands as body-marks to show a posture with 100% stretch. Once the participant grasps the concept the routine will begin with 5 minutes of warm-up, followed by stretching exercises targeting 10 anatomical groups. Each posture will last 1 minute divided in 30 seconds of settling into each posture and 30 seconds of holding. Each session will be video recorded to analyze the stretching range, only if the participant agrees at the informed consent visit. Participants will be encouraged to find their own 100% with some feedback from the instructor.

Procedure: Yoga-based stretching

Interventions

Different yoga postures (ASANA) were isolated from conventional yoga practice to stretch different muscle groups. Muscle groups stretched: hip extensor and adductors, hip \& plantar flexors, shoulder extensors, shoulder horizontal adductors, shoulder extensors-adductor, wrist flexor, trunk extensors, lateral flexors, and trunk rotators.

Stretching protocol 1, Mild Stretching Group (MSG)Stretching protocol 2, Intense Stretching Group (ISG):

Eligibility Criteria

Age40 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy adults
  • Age between 40 - 60 years old.
  • Non-smoking
  • BMI between 19 and 29.

You may not qualify if:

  • Any history of chronic inflammatory disease or recent acute illness (\< 1 month)
  • Vaccination within the last 3 months
  • Regular medication, or any medication in the preceding week
  • Practice of structured higher-intensity exercise at least twice a week for more than 30 minutes
  • Pregnancy
  • Endocrine disorders (e.g. diabetes)
  • Significant soft tissue injury
  • Surgical supportive devices (nails, wire, screws, pins, plates) in an area of the body to be stretched (toes, ankles, knees, hips, shoulders, elbows, wrists, fingers and spine)
  • Fractures in the past 3 years
  • Generalized joint hypermobility or genetic conditions such as Marfan syndrome and Ehlers-Danlos syndrome
  • Alcoholism (\> 10 drinks per week) and drug abuse.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ambulatory Clinical Center (ACC)

Boston, Massachusetts, 02115, United States

Location

Related Publications (13)

  • Ding D, Stamatakis E. Yoga practice in England 1997-2008: prevalence, temporal trends, and correlates of participation. BMC Res Notes. 2014 Mar 24;7:172. doi: 10.1186/1756-0500-7-172.

  • Tindle HA, Davis RB, Phillips RS, Eisenberg DM. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med. 2005 Jan-Feb;11(1):42-9.

  • Clarke TC, Barnes PM, Black LI, Stussman BJ, Nahin RL. Use of Yoga, Meditation, and Chiropractors Among U.S. Adults Aged 18 and Over. NCHS Data Brief. 2018 Nov;(325):1-8.

  • Kiecolt-Glaser JK, Bennett JM, Andridge R, Peng J, Shapiro CL, Malarkey WB, Emery CF, Layman R, Mrozek EE, Glaser R. Yoga's impact on inflammation, mood, and fatigue in breast cancer survivors: a randomized controlled trial. J Clin Oncol. 2014 Apr 1;32(10):1040-9. doi: 10.1200/JCO.2013.51.8860. Epub 2014 Jan 27.

  • Ospina MB, Bond K, Karkhaneh M, Tjosvold L, Vandermeer B, Liang Y, Bialy L, Hooton N, Buscemi N, Dryden DM, Klassen TP. Meditation practices for health: state of the research. Evid Rep Technol Assess (Full Rep). 2007 Jun;(155):1-263.

  • Ebnezar J, Nagarathna R, Yogitha B, Nagendra HR. Effect of integrated yoga therapy on pain, morning stiffness and anxiety in osteoarthritis of the knee joint: A randomized control study. Int J Yoga. 2012 Jan;5(1):28-36. doi: 10.4103/0973-6131.91708.

  • Langevin HM. Connective tissue: a body-wide signaling network? Med Hypotheses. 2006;66(6):1074-7. doi: 10.1016/j.mehy.2005.12.032. Epub 2006 Feb 17.

  • Benias PC, Wells RG, Sackey-Aboagye B, Klavan H, Reidy J, Buonocore D, Miranda M, Kornacki S, Wayne M, Carr-Locke DL, Theise ND. Structure and Distribution of an Unrecognized Interstitium in Human Tissues. Sci Rep. 2018 Mar 27;8(1):4947. doi: 10.1038/s41598-018-23062-6.

  • Wosczyna MN, Rando TA. A Muscle Stem Cell Support Group: Coordinated Cellular Responses in Muscle Regeneration. Dev Cell. 2018 Jul 16;46(2):135-143. doi: 10.1016/j.devcel.2018.06.018.

  • Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN. Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol. 2001 Jul;2(7):612-9. doi: 10.1038/89759.

  • Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol. 2005 Dec;6(12):1191-7. doi: 10.1038/ni1276.

  • Berrueta L, Muskaj I, Olenich S, Butler T, Badger GJ, Colas RA, Spite M, Serhan CN, Langevin HM. Stretching Impacts Inflammation Resolution in Connective Tissue. J Cell Physiol. 2016 Jul;231(7):1621-7. doi: 10.1002/jcp.25263. Epub 2015 Dec 10.

  • Munoz-Vergara D, Schreiber KL, Langevin H, Yeh GY, Zhu Y, Rist P, Wayne PM. The Effects of a Single Bout of High- or Moderate-Intensity Yoga Exercise on Circulating Inflammatory Mediators: A Pilot Feasibility Study. Glob Adv Health Med. 2022 Dec 11;11:2164957X221145876. doi: 10.1177/2164957X221145876. eCollection 2022.

MeSH Terms

Conditions

InflammationFasciitisMusculoskeletal PainLow Back PainNeck Pain

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsMusculoskeletal DiseasesMuscular DiseasesPainNeurologic ManifestationsSigns and SymptomsBack Pain

Study Officials

  • Peter M Wayne, PhD

    Brigham and Women's Hospital and Harvard University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Participants and yoga-based stretching instructor are not blinded. Nurses and lab technicians are blinded during blood draws. Laboratory analysts are blinded during sample analyses. Statisticians will be unblinded once all laboratory analyses are completed.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: The present study is a pilot randomized clinical trial (RCT) with 3 arms. These arms are: Control Group, Mild Stretching Group, and Intense Stretching Group. Ten participants will be allocated in each arm.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 23, 2020

First Posted

June 23, 2020

Study Start

January 30, 2020

Primary Completion

May 30, 2024

Study Completion

September 30, 2024

Last Updated

January 16, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

The results of this study may eventually be published, and information may be exchanged between medical investigators and collaborators, but patient confidentiality will be maintained. Institutional Review Board and regulatory authorities will be granted direct access to original medical and research records for verification of clinical trial procedures and/or data. If the record is used or disseminated for government purposes, it will be done under conditions that will protect the subject's privacy consistent with laws relating to public disclosure of information and the law-enforcement responsibilities of the agency (e.g. NIH and FDA).

Locations